The global non-hodgkin's lymphoma therapeutics market size is accounted at USD 10.99 billion in 2025 and is forecasted to hit around USD 20.94 billion by 2034, representing a CAGR of 7.43% from 2025 to 2034. The North America market size was estimated at USD 4.40 billion in 2024 and is expanding at a CAGR of 7.54% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Non-Hodgkin’s Lymphoma Therapeutics Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Non-Hodgkin’s Lymphoma Therapeutics Market, by Therapy Type
8.1.1. Radiation Therapy
8.1.1.1. Market Revenue and Forecast
8.1.2. Chemotherapy
8.1.2.1. Market Revenue and Forecast
8.1.3. Targeted Therapy
8.1.3.1. Market Revenue and Forecast
8.1.4. Other
8.1.4.1. Market Revenue and Forecast
9.1. Non-Hodgkin’s Lymphoma Therapeutics Market, by Cell Type
9.1.1. B Cell
9.1.1.1. Market Revenue and Forecast
9.1.2. T Cell
9.1.2.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Therapy Type
10.1.2. Market Revenue and Forecast, by Cell Type
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Therapy Type
10.1.3.2. Market Revenue and Forecast, by Cell Type
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Therapy Type
10.1.4.2. Market Revenue and Forecast, by Cell Type
10.2. Europe
10.2.1. Market Revenue and Forecast, by Therapy Type
10.2.2. Market Revenue and Forecast, by Cell Type
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Therapy Type
10.2.3.2. Market Revenue and Forecast, by Cell Type
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Therapy Type
10.2.4.2. Market Revenue and Forecast, by Cell Type
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Therapy Type
10.2.5.2. Market Revenue and Forecast, by Cell Type
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Therapy Type
10.2.6.2. Market Revenue and Forecast, by Cell Type
10.3. APAC
10.3.1. Market Revenue and Forecast, by Therapy Type
10.3.2. Market Revenue and Forecast, by Cell Type
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Therapy Type
10.3.3.2. Market Revenue and Forecast, by Cell Type
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Therapy Type
10.3.4.2. Market Revenue and Forecast, by Cell Type
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Therapy Type
10.3.5.2. Market Revenue and Forecast, by Cell Type
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Therapy Type
10.3.6.2. Market Revenue and Forecast, by Cell Type
10.4. MEA
10.4.1. Market Revenue and Forecast, by Therapy Type
10.4.2. Market Revenue and Forecast, by Cell Type
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Therapy Type
10.4.3.2. Market Revenue and Forecast, by Cell Type
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Therapy Type
10.4.4.2. Market Revenue and Forecast, by Cell Type
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Therapy Type
10.4.5.2. Market Revenue and Forecast, by Cell Type
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Therapy Type
10.4.6.2. Market Revenue and Forecast, by Cell Type
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Therapy Type
10.5.2. Market Revenue and Forecast, by Cell Type
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Therapy Type
10.5.3.2. Market Revenue and Forecast, by Cell Type
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Therapy Type
10.5.4.2. Market Revenue and Forecast, by Cell Type
11.1. AstraZeneca Plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Bayer AG
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. F. Hoffmann La-Roche Ltd
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. GlaxoSmithKline Plc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Seagen Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Takeda Pharmaceutical Company Limited
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Janssen Pharmaceuticals Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Eli Lilly
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Spectrum Pharmaceuticals Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample